Company news
Tasly Pharmaceutical Group Co. Ltd. news in 2025
Tasly Pharmaceutical Group Co. Ltd.'s news releases, calls and decks from 2025, newest first.
Announcement on Resolutions of the 6th Extraordinary General Meeting in 2025
December 26, 2025
Announcement on Estimated Related Party Transactions of Daily Operations in 2026
December 9, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 26, 2025
Announcement on Resolutions of the 15th Meeting of the 9th Board of Directors
October 24, 2025
Announcement on Obtaining Drug Registration Certificate for Wenjing Decoction Granules
October 13, 2025
Announcement on Resolutions of the 5th Extraordinary General Meeting in 2025
October 10, 2025
Announcement on Implementation of Semi-annual Dividend Distribution for 2025
October 9, 2025
Announcement on Obtaining Notice of Approval for Drug Clinical Trial
September 24, 2025
Announcement on Acquisition of Drug Registration Certificate for New Indication of Acute Ischemic Cerebral Stroke of the Wholly-owned Subsidiary's Reocmbinant Human Prourokinase for Injection
September 22, 2025
Announcement on Using Idle Funds to Purchase Bank Financial Products
September 17, 2025
Announcement on Progress in Providing Guarantee for Subsidiary
September 15, 2025
Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction
September 5, 2025
Announcement on Resolutions of the 13th Meeting of the 9th Board of Directors
September 2, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
August 20, 2025
2025 Semi-annual Report
August 15, 2025
Announcement on Appointment of Senior Management Members
August 6, 2025
Announcement on Expiration of Duration and Termination of the Employee Stock Ownership Plan
July 23, 2025
Announcement on the Progress of Drug Registration Application
July 18, 2025
Announcement on Resolutions of the 10th Meeting of the 9th Board of Directors
July 15, 2025
Announcement on Obtaining Drug Registration Certificate for D-Glucosamine Sulfate Capsules by Wholly-owned Subsidiary
June 10, 2025
Announcement on Obtaining Drug Registration Certificate for Torasemide Injection by Wholly-owned Subsidiary
May 28, 2025
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
May 14, 2025
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2025
May 7, 2025
Announcement on Key Operating Data for Q1 2025
April 28, 2025
Announcement on Resolutions of the 6th Meeting of the 9th Board of Supervisors
April 15, 2025
Announcement on Election of Employee Director
April 14, 2025
Announcement on Amending the "Articles of Association"
March 28, 2025
Announcement on Resignation of Some Directors and Supervisors
March 27, 2025
Announcement on Implementation of Annual Dividend Distribution in 2024
March 19, 2025
Announcement on Resolution of the 2024 Annual General Meeting
March 17, 2025
Announcement on Providing Online Voting Reminder Service for General Meeting
March 13, 2025
Announcement on Adding Special Proposals to 2024 Annual General Meeting
March 7, 2025
Announcement on Signing the Supplementary Agreement to the Share Transfer Agreement by the Controlling Shareholder and Persons Acting in Concert
February 28, 2025
Notice on Convening the Annual General Meeting in 2024
February 24, 2025